As of May 01
| +1.73 / +2.15%|
The 8 analysts offering 12-month price forecasts for Clovis Oncology Inc have a median target of 100.00, with a high estimate of 117.00 and a low estimate of 85.00. The median estimate represents a +21.82% increase from the last price of 82.09.
The current consensus among 8 polled investment analysts is to Buy stock in Clovis Oncology Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.